FindTrial
Sign In

The comparison of the diagnosis of antiphospholipid syndrome between using revised Sapporo criteria and 2023 ACR/EULAR antiphospholipid syndrome classification criteria in Thai patients at Siriraj hospital

The comparison of the diagnosis of antiphospholipid syndrome between using revised Sapporo criteria and 2023 ACR/EULAR antiphospholipid syndrome classification criteria in Thai patients at Siriraj hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20250527003
Enrollment
300
Registered
2025-05-27
Start date
2024-03-08
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antiphospholid syndrome Antiphospholipid syndrome Thrombosis

Interventions

Antiphospholipid syndrome patients who met both Revised Sapporo criteria and 2023 ACR/EULAR antiphospholipid syndrome classification criteria,Antiphospholipid syndrome patients who met only Revised Sa
Diagnostic,Diagnostic
ACR/EULAR criteria-met group ,ACR/EULAR criteria-unmet group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
15 Years to 101 Years

Inclusion criteria

Inclusion criteria: 1. Patients age more than 15 years old 2. Patients with diagnosis of antiphospholipid syndrome in Siriraj hospital since 2013 - 2023

Exclusion criteria

Exclusion criteria: Follow up time less than 1 month

Design outcomes

Primary

MeasureTime frame
number of patients met with the criteria 10 years number and percent—

Secondary

MeasureTime frame
Number of patients who had discordant diagnosis from both criteria 10 years number and percent—

Countries

Thailand

Contacts

Public ContactSitanun Preechathaveekid

Faculty of Medicine, Siriraj hospital, Mahidol university

psitanun@gmail.com024194449

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026